Shire said it will acquire Dyax, which markets Kalbitor; Citron doesn't plan to release any additional allegations against Valeant; Myriad Genetics launches social-media campaign
from Most popular articles from Medical Marketing and Media http://ift.tt/1Mue21K
No comments:
Post a Comment